GP judgment beats BNP

March 2008
Pulse;3/5/2008, Vol. 68 Issue 8, p3
The article reports on the result of the study on the B-type natriuretic peptide (BPN) testing in patients with suspected heart failure. The study suggests that general practitioners would do better relying on their clinical judgment than BNP testing. According to the study, BNP testing performed less well than a risk score based on common signs and symptoms.


Related Articles

  • Natriuretic Peptides: Putting the Evidence into Practice. Andrade, Ada; Sharar, Haytham // Canadian Journal of Cardiovascular Nursing;2008, Vol. 18 Issue 4, p34 

    With advances in cardiovascular medicine, people are living longer with cardiovascular disease. There is an increased incidence and prevalence of heart failure. Misdiagnosis of heart failure, particularly in the early stages, is not uncommon. Natriuretic peptides (BNP and NT-proBNP) have been...

  • Neseritide. Caron, Michael F.; White, C. Michael // Formulary;Sep2001, Vol. 36 Issue 9, p639 

    Examines the effects of a brain natriuretic peptide Nesiritide for treating patients with acutely decompensated congestive heart failure. Reduction of pulmonary capillary wedge pressure using nesiritide; Association between nesiritide and arrhythmic events; Need for blood pressure monitoring...

  • Nesiritide: A Review of its Use in Acute Decompensated Heart Failure. Keating, G.M.; Goa, K.L. // Drugs;2003, Vol. 63 Issue 1, p47 

    Nesiritide (Natrecor) is a recombinant form of human B-type (brain) natriuretic peptide that has beneficial vasodilatory, natriuretic, diuretic and neurohormonal effects. The drug is administered intravenously for the management of patients with decompensated congestive heart failure (CHF). In...

  • Natriuretic peptides: Diagnostic and therapeutic use. Pandit, Kaushik; Mukhopadhyay, Pradip; Ghosh, Sujoy; Chowdhury, Subhankar // Indian Journal of Endocrinology & Metabolism;Oct2011 Supplement, pS345 

    Natriuretic peptides (NPs) are hormones which are mainly secreted from heart and have important natriuretic and kaliuretic properties. There are four different groups NPs identified till date [atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), C-type natriuretic peptide (CNP)...

  • NILE PURSUES POST-ACUTE INDICATION IN HEART FAILURE.  // Biotech Business;Apr2011, Vol. 24 Issue 4, p8 

    The article reports on the plan of U.S.-based Nile Therapeutics Inc. to pursue a post-acute indication in heart failure. The company seeks to develop the natriuretic peptide cenderitide as an outpatient therapy for patients with acutely decompensated heart failure (ADHF). Sustained cardiac and...

  • Nesiritide and heart failure. Elliott, William T. // Infectious Disease Alert;Sep2011 Pharmacology Watch, p2 

    The article focuses on a study which examined the safety and efficacy of nesiritide in treating patients with acute heart failure.

  • Kalos Hits Financing Trail for Peptide-Based MAPK Inhibitor. Morrison, Trista // BioWorld Today;11/5/2009, Vol. 20 Issue 214, p1 

    The article reports on the efforts of Kalos Therapeutics Inc. to begin clinical trials with atrial natriuretic peptide KT-220. These peptides, which are known for their cardiovascular applications, are said to be produced by the heart in response to conditions like congestive heart failure....

  • B-type natriuretic peptide and weaning from mechanical ventilation. Mekontso-Dessap, Armand; Prost, Nicolas; Girou, Emmanuelle; Braconnier, François; Lemaire, François; Brun-Buisson, Christian; Brochard, Laurent; de Prost, Nicolas; Braconnier, François; Lemaire, François // Intensive Care Medicine;Oct2006, Vol. 32 Issue 10, p1529 

    Objective: Cardiac function and volume status could play a critical role in the setting of weaning failure. B-type natriuretic peptide (BNP) is a powerful marker of cardiac dysfunction. We assessed the value of BNP during the weaning process.Design, Setting and Patients:...

  • Cut-off values for B-type natriuretic peptides in Korean patients visiting emergency departments. Sunghyuk Choi // Emergency Medicine Journal;Apr2008, Vol. 25 Issue 4, p246 

    A response by Sunghyuk Choi to a letter to the editor about their article on the use of natriuretic peptides in diagnosing congestive heart failure in Korean patients with dyspnea is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics